GBT-009

N/A

Report date: 2025/04/28 22:35:30

Base Information

Drug NameGBT-009
Drug Alias NameGBT-009
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionIntercellular signaling peptides and proteins stimulantsCytokines stimulants
TargetsCytokinesIntercellular signaling peptides and proteins
Therapy Area/IndicationsCicatrixMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGarnet Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuronyx CorpGarnet Biotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsCicatrixMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A